APPLICATION OF EP4 RECEPTOR ANTAGONISTS FOR TREATMENT OF NASH-ASSOCIATED LIVER CANCER

• 收藏
• 分享

专利权人:

АСКАТ ИНК. (JP)

发明人:

ОТАНИ, Наоко (JP),КАМАТИ, Фумитака (JP),ЛОО, Тзе Мун (JP),КОИДЗУМИ, Синити (JP),ОКУМУРА, Такако (JP)

申请号：

RU2020109376

公开号：

RU2020109376A

申请日:

2017.11.02

申请国别(地区):

RU

年份:

2020

代理人:

摘要：

This invention is directed to prostaglandin E2 receptor 4 (EP4) antagonists useful in the treatment of nonalcoholic steatohepatitis (NASH)-associated liver cancer in a human or animal. The method comprises administering one or more of Compound A, Compound B or Compound C, or pharmaceutically acceptable salts thereof, as the EP4 antagonist(s). The method may include a pharmaceutical composition comprising the EP4 antagonist, and may include one or more other active agents and/or therapies.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/